Pink October has become an essential month to talk about breast cancer, which affects more than 60,000 women each year and causes around 12,000 deaths per year in France. Depending on their stage of development, their location in the organ, the cells from which they spread or even the presence of hormonal receptors, breast cancers differ, as do the therapeutic responses. What treatments exist today and what are the medical advances? Elements of response with Professor Anne Vincent-Salomon, pathologist and director of the Women’s Cancer Institute which brings together the Institut Curie, the University of Paris Sciences & Lettres, as well as Inserm.
